[1]Patent:EP3248980,2017,A1
[1]Patent:EP3248980,2017,A1.Locationinpatent:Paragraph0065;0066;0070
[1]CurrentPatentAssignee:WUXIFORTUNEPHARMACEUTICAL-EP3248980,2017,A1Locationinpatent:Paragraph0115;0116;0118
176523-95-8
205194-12-3
5006-62-2
5166-67-6
37675-19-7
301180-05-2
933852-41-6 | 2-(4,5-dimethyl-3-thienyl)ethanamine | AA00GVMF | MFCD11053951
936940-12-4 | 1-(1,3,5-Trimethyl-1h-pyrazol-4-yl)ethanamine | AA00GVQX | MFCD05864525
88040-25-9 | Δ2-Cefepime | AA00GVVR
939-38-8 | (S)-Phenylephrine hydrochloride | AA00GWIL | MFCD06809888
903513-59-7 | 2-(tert-ButoxycarbonylaMino)pyridin-4-ylboronic acid | AA00GX1E | MFCD13188969
94061-81-1 | Sodium (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoate | AA00GXJN | MFCD08063391
886496-87-3 | (3-Chloro-5-(trifluoromethyl)phenyl)methanol | AA00GY10 | MFCD04115848
887973-46-8 | 5-(2,4-Difluorophenyl)nicotinic acid | AA00GYGU | MFCD06410287
887591-62-0 | 1-Boc-3-methylazetidine-3-carboxylic acid | AA00GZN0 | MFCD12406581
919077-81-9 | GP 2A | AA00H08A | MFCD09971118